Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guozhe Sun

Showing results (81-90 of 103) with videos related to

Pageof 11
Sort By:
Journal of Advanced Research|October 1, 2025
Evaluating intensive blood pressure control versus usual care on cardiovascular disease in patients with diabetes using win statistics: a subgroup analysis of a cluster randomized trialGuozhe Sun, Ning Ye, Chang Wang, et al.
International Journal of Biological Macromolecules|March 20, 2024
Regulation of lipid metabolism by E3 ubiquitin ligases in lipid-associated metabolic diseasesYuanming Zou, Ying Zhang, Mohan Li, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|July 6, 2024
The role of serine/threonine protein kinases in cardiovascular disease and potential therapeutic methodsYanjiao Wu, Yuanming Zou, Chunyu Song, et al.
JAMA Network Open|July 11, 2025
Intensive Systolic Blood Pressure Reduction and Kidney and Cardiovascular Outcomes: A Secondary Analysis of a Randomized Clinical TrialGuozhe Sun, Wei Miao, Songyue Liu, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 7, 2026
Corrigendum to "The role of serine/threonine protein kinases in cardiovascular disease and potential therapeutic methods" [Biomed. Pharmacother. 177 (2024) 117093]Yanjiao Wu, Yuanming Zou, Chunyu Song, et al.
Basic Research in Cardiology|November 8, 2023
The role of glycolytic metabolic pathways in cardiovascular disease and potential therapeutic approachesShuxian Chen, Yuanming Zou, Chunyu Song, et al.
Nature Medicine|April 21, 2025
Blood pressure reduction and all-cause dementia in people with uncontrolled hypertension: an open-label, blinded-endpoint, cluster-randomized trialJiang He, Chuansheng Zhao, Shanshan Zhong, et al.
American Journal of Hypertension|February 19, 2021
Rationale and Design of a Cluster Randomized Trial of a Village Doctor-Led Intervention on Hypertension Control in ChinaYingxian Sun, Zhao Li, Xiaofan Guo, et al.
Journal of the American Heart Association|March 13, 2025
Intensive Blood Pressure Strategy on Cardiovascular Diseases in Patients With Metabolic Syndrome: Post Hoc Analysis of a Clinical TrialGuozhe Sun, Xiaofan Guo, Guangxiao Li, et al.
Lancet (London, England)|May 2, 2022
A village doctor-led multifaceted intervention for blood pressure control in rural China: an open, cluster randomised trialYingxian Sun, Jianjun Mu, Dao Wen Wang, et al.
Pageof 11

Showing results (81-90 of 103) with videos related to

Sort By:
Pageof 11
Journal of Advanced Research|October 1, 2025
Evaluating intensive blood pressure control versus usual care on cardiovascular disease in patients with diabetes using win statistics: a subgroup analysis of a cluster randomized trialGuozhe Sun, Ning Ye, Chang Wang, et al.
International Journal of Biological Macromolecules|March 20, 2024
Regulation of lipid metabolism by E3 ubiquitin ligases in lipid-associated metabolic diseasesYuanming Zou, Ying Zhang, Mohan Li, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|July 6, 2024
The role of serine/threonine protein kinases in cardiovascular disease and potential therapeutic methodsYanjiao Wu, Yuanming Zou, Chunyu Song, et al.
JAMA Network Open|July 11, 2025
Intensive Systolic Blood Pressure Reduction and Kidney and Cardiovascular Outcomes: A Secondary Analysis of a Randomized Clinical TrialGuozhe Sun, Wei Miao, Songyue Liu, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 7, 2026
Corrigendum to "The role of serine/threonine protein kinases in cardiovascular disease and potential therapeutic methods" [Biomed. Pharmacother. 177 (2024) 117093]Yanjiao Wu, Yuanming Zou, Chunyu Song, et al.
Basic Research in Cardiology|November 8, 2023
The role of glycolytic metabolic pathways in cardiovascular disease and potential therapeutic approachesShuxian Chen, Yuanming Zou, Chunyu Song, et al.
Nature Medicine|April 21, 2025
Blood pressure reduction and all-cause dementia in people with uncontrolled hypertension: an open-label, blinded-endpoint, cluster-randomized trialJiang He, Chuansheng Zhao, Shanshan Zhong, et al.
American Journal of Hypertension|February 19, 2021
Rationale and Design of a Cluster Randomized Trial of a Village Doctor-Led Intervention on Hypertension Control in ChinaYingxian Sun, Zhao Li, Xiaofan Guo, et al.
Journal of the American Heart Association|March 13, 2025
Intensive Blood Pressure Strategy on Cardiovascular Diseases in Patients With Metabolic Syndrome: Post Hoc Analysis of a Clinical TrialGuozhe Sun, Xiaofan Guo, Guangxiao Li, et al.
Lancet (London, England)|May 2, 2022
A village doctor-led multifaceted intervention for blood pressure control in rural China: an open, cluster randomised trialYingxian Sun, Jianjun Mu, Dao Wen Wang, et al.
Pageof 11